Journal of Alzheimer's & Dementia Open Access

  • Journal h-index: 2
  • Journal CiteScore: 0.15
  • Journal Impact Factor: 0.26
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days

Dr. Giannakopoulos Panteleimon

Dr. Giannakopoulos Panteleimon
Medical Director
University of Geneva, Division of Instituional Measures (Forensic Psychiatry), University of Geneva Hospitals and Professor, Faculty of Medicine, Switzerland


Born in 1965 in Greece, I obtained my MD degree in the University of Athens in 1989 before completing a full training on psychiatry and psychotherapy in London (Maudsley Hospital and Geneva) as well as postdoc training in Paris (La Pitié-Sâlpetrière Hospital, Federation of Neurology). My psychiatric education combined early exposure to neurobiology and classical psychoanalytic training. In fact, the postgraduate training in Switzerland (6 years) includes both aspects and allowed for obtaining a double board certification (psychiatrist and psychotherapist). In 1998, aged 33 years, I have been appointed as associate professor and medical head of the Division of Geriatric Psychiatry of the University Hospitals of Geneva. Later on (2004) I obtained the position of full tenured professor of Psychiatry in the University of Geneva. From 2003 to 2011, I also assumed a parallel position of full professor of Old Age Psychiatry in the University of Lausanne in order to promote the academic careers of junior staff locally. An important part of my duties concerns the management and organization of psychiatric care for the Geneva state as Chairman of the Department of Mental Health and Psychiatry (2005-2015). My research field was initially that of the functional neuroanatomy of dementing conditions and may be illustrated by a series of clinico-pathological studies aiming to determine the relative weight of each aging-related lesion in cognitive deterioration. This work was made in close collaboration with the Department of Geriatrics and the Division of Neuropsychiatry of the University Hospitals of Geneva and the Department of Neuroscience of the Mount Sinai Hospital, NY. These ex vivo observations on neuropathological markers of dementia have been at the origin of an in vivo complement focusing on the identification of predictive markers of rapid cognitive decline in elderly controls. In addition to this hospital position, I have been for 8 years vice dean of the Faculty of Medicine in the University of Geneva having the responsibility of postgraduate and continuous education

Research Interest

Psychiatry and Psychotherapy